11C-mHED for PET / CT: Principles of synthesis, methodology and first clinical applications

Current Radiopharmaceuticals

Volumn 7, Issue 2, 2014, Pages 79-83

  Bonfiglioli, Rachele ^a   Nanni, Cristina ^a   Martignani, Cristian ^a   Zanoni, Lucia ^a   La Donna, Raffaele ^a   Diemberger, Igor ^a   Boriani, Giuseppe ^a   Pettinato, Cinzia ^a   Sambuceti, Gianmario ^b   Fanti, Stefano ^a   Mansi, Luigi ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

11C meta hydroxy ephedrine; Cardiac imaging; Norepinephrine; Sympathetic innervations

Indexed keywords

3 HYDROXYEPHEDRINE; 3 HYDROXYEPHEDRINE C 11; TRACER; UNCLASSIFIED DRUG; 3-HYDROXYEPHEDRINE; CARBON; EPHEDRINE; RADIOPHARMACEUTICAL AGENT;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG DISTRIBUTION; DRUG SYNTHESIS; HEART INNERVATION; HUMAN; ISOTOPE LABELING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; AUTONOMIC NEUROPATHY; DIAGNOSTIC USE; DOSE RESPONSE; HEART; HEART DISEASE; HEART MUSCLE; IMAGE PROCESSING; INNERVATION; METABOLISM; PROCEDURES; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TIME;

AUTONOMIC NERVOUS SYSTEM DISEASES; CARBON RADIOISOTOPES; DOSE-RESPONSE RELATIONSHIP, DRUG; EPHEDRINE; HEART; HEART DISEASES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84921778155     PISSN: 18744710     EISSN: 18744729     Source Type: Journal    
DOI: 10.2174/1874471007666140714111304     Document Type: Article

References (33)

1. The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N. Engl. J. Med., 1981, 304, 801.
2. Beta-blocker Heart Attack Study Group. The beta-blocker heart attack trial (BHAT). JAMA, 1981, 246, 2073.
3. Swedberg, K.; Hjalmarson, A.; Waagstein, F.; Wallentin, I. Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. Br, Heart J., 1980, 44, 117-133.
4. Waagstein, F.; Caidahl, K.; Wallentin, I.; Bergh, C.H.; Hjalmarson, A. Long-term,²-blockade in dilated cardiomyopathy: Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. Circulation, 1989, 80, 551-563.
5. Brisinda, D.; Sorbo, A.R.; Di Giacopo, R.; Venuti, A.; Bentivoglio, A.R.; Fenici, R. Cardiovascular autonomic nervous system evaluation in Parkinson disease and multiple system atrophy. J. Neurol. Sci., 2014, 15, 336(1-2), 197-202.
6. Fowler, M.B.; Laser, J.A.; Hopkins, G.L.; Minobe, W.; Bristow, M.R. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and sub-sensitivity to agonist response. Circulation, 1986, 74(6), 1290-1302.
7. Cha, Y.M.; Oh, J.; Miyazaki, C.; Hayes, D.L.; Rea, R.F.; Shen, W.K.; Asirvatham, S.J.; Kemp, B.J.; Hodge, D.O.; Chen, P.S.; Chareonthaitawee, P. Cardiac Resynchronization Therapy Upregulates Cardiac Autonomic Control. J. Cardiovasc. Electrophysiol., 2008, 19(10), 1045-1052.
8. Goldstein, D.S.; Brush, J.E. Jr, Eisenhofer, G.; Stull, R.; Esler, M. In vivo measurement of neuronal uptake of norepinephrine in the human heart. Circulation, 1988, 78, 41-48.
9. Glowniak, J.V.; Turner, F.E.; Gray, L.L.; Palac, R.T.; Lagunas- Solar, M.C.; Woodward, W.R. Iodine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants. J. Nucl. Med., 1989, 30(7), 1182-1191.
10. Henderson, E.B.; Kahn, J.K.; Corbett, J.R.; Jansen, D.E.; Pippin, J.J.; Kulkarni, P.; Ugolini, V.; Akers, M.S.; Hansen, C.; Buja, L.M. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation, 1988, 78(5 Pt. 1), 1192-1199.
11. Barber, M.J.; Mueller, T.M.; Henry, D.P.; Felten, S.Y.; Zipes, D.P. Transmural myocardial infarction in the dog produces sympathectomy in non-infarcted myocardium. Circulation, 1983, 67(4), 787-796.
12. Cuccurullo, V.; Mansi, L. Toward tailored medicine (and beyond): the phaeochromocytoma and paraganglioma model. Eur. J. Nucl. Med. Mol. Imaging, 2012, 39(8), 1262-1265
13. Biffi, M.; Fallani, F.; Boriani, G.; Fanti, S.; Kowoll, L.; Pettinato, C.; Monetti, N.; Branzi, A. Abnormal cardiac innervation in patients with idiopathic ventricular fibrillation. Pacing Clin. Electrophysiol., 2003, 26(1 Pt. 2), 357-360.
14. Goldstein, D.S.; Chang, P.C.; Eisenhofer, G.; Miletich, R.; Finn, R.; Bacher, J.; Kirk, K.L.; Bacharach, S.; Kopin, I.J. Positron emission tomographic imaging of cardiac sympathetic innervation and function. Circulatio, 1990, 81, 1606-1621.
15. Fowler, JS, Ansari AN, Atkins HL, Bradley-Moore PR, MacGregor RR, Wolf A.P. Synthesis and preliminary evaluation in animals of carrier-free 11C -1-dopamine hydrochloride: X. J. Nucl. Med., 1973, 14, 867-869.
16. Ding, Y.S.; Fowler, J.S.; Gatley, S.J.; Dewey, S.L.; Wolf, A.P. Synthesis of high Specific activity (+)- and (-)-6-[18F] fluoronorepinephrine via the nucleophilic aromatic substitution reaction. J. Med. Chem., 1991, 34, 767-771.
17. Chakraborty, P.K.; Gildersleeve, D.L.; Jewett, D.M.; Toorongian, S.A.; Kilbourn, M.R.; Schwaiger, M.; Wieland, D.M. High yield synthesis of high specific activity R-(-)-[11C]epinephrine for routine PET studies in humans. Nucl. Med. Biol., 1993, 20(8), 939-944.
18. Zhang, H.; Huang, R.; Pillarsetty, N.; Thorek, D.L.; Vaidyanathan, G.; Serganova, I.; Blasberg, R.G.; Lewis, J.S. Synthesis and evaluation of 18F labelled benzylguanidine analogs for targeting the human norepinephrine transporter. Eur. J. Nucl. Med. Mol. Imaging, 2014, 41(2), 322-332.
19. Schwaiger, M.; Hutchins, G.D.; Kalif, V.; Rosenspire, K.; Haka, M.S.; Mallette, S.; Deeb, G.M.; Abrams, G.D.; Wieland, D. Evidence for regional catecholamine uptake and storage sites in the transplanted human heart by positron emission tomography. J. Clin. Invest., 1991, 87, 1681-1690.
20. Hutchins, G.D.; Schwaiger, M.; Haka, M.S. Compartmental analysis of catecholamine analogs in myocardial tissue [Abstract]. J. Nucl. Med., 1989, 30, 735.
21. Lodi, F.; Rizzello, A.; Carpinelli, A.; Di Pierro, D.; Cicoria, G.; Mesisca, V.; Marengo, M.; Boschi, S. Automated Synthesis of [11C]Meta Hydroxyephedrine, a PET Radiopharmaceutical for Studying Sympathetic Innervation in the Heart. Comp. Cardiol., 2008, 35, 341-343.
22. Rosenspire, K.C.; Haka, M.S.; Van Dort, M.E.; Jewett, D.M.; Gildersleeve, D.L.; Schwaiger, M.; Wieland, D.M. Synthesis and preliminary evaluation of carbon-11-meta-hydroxyephedrine: a false transmitter agent for heart neuronal imaging. J. Nucl. Med., 1990, 31(8), 1328-1334.
23. Hartmann, F.; Ziegler, S.; Nekolla, S.; Hadamitzky, M.; Seyfarth, M.; Richardt, G.; Schwaiger, M. Regional patterns of myocardial sympathetic denervation in dilated cardiomyopathy: an analysis using carbon-11 hydroxyephedrine and positron emission tomography. Heart, 1999, 81(3), 262-270.
24. Sisson, J.C.; Wieland, D.M. Radiolabeled metaiodobenzylguanidine: Pharmacology and clinical studies. Am. J. Physiol. Imaging, 1986, 1, 96-103.
25. Cascini, G.L.; Cuccurullo, V.; Tamburrini, O.; Rotondo, A.; Mansi, L. Neurological applications for myocardial MIBG scintigraphy. Nucl. Med. Rev. Cent. East Eur., 2013, 16(1), 35-41.
26. Schwaiger, M.; Guibourg, H.; Rosenspire, K.; McClanahan, T.; Gallagher, K.; Hutchins, G.; Wieland, D.M. Effect of regional myocardial ischemia on sympathetic nervous system as assessed by fluorine-18 metaraminol. J. Nucl. Med., 1990, 31, 1352-1357.
27. Schwaiger, M.; Kaiff, V.; Rosenspire, K.; Haka, M.S.; Molina, E.; Hutchins, G.D.; Deeb, M.; Wolfe, E. Jr.; Wieland, D.M. Noninvasive evaluation of Sympathetic nervous system in human heart by positron emission tomography. Circulation, 1990, 82, 457-464.
28. Sunderland, P.M. Pathophysiology. The Biologic basis for disease in adults and children, K.L.McCance, and S. E. Huether, Editor. 1994, Mosby-Year Books, Inc.: St, Louiis. pP. 397-436.
29. Buursma, A.R., Beerens, A.M.; de Vries, E.F.; van Waarde, A.; Rots, M.G.; Hospers, G.A.; Vaalburg, W.; Haisma, H.J. The Human Norepinephrine Transporter in Combination with 11C-m- Hydroxyephedrineas a Reporter Gene/Reporter Probe for PET of Gene Therapy. J. Nucl. Med., 2005, 46(12), 2068-2075.
30. Caldwell, J.H.; Kroll, K.; Li, Z.; Seymour, K.; Link, J.M.; Krohn, K.A. Quantitation of Presynaptic Cardiac Sympathetic Function with Carbon-11 -Meta-Hydroxyephedrine. J. Nucl. Med., 1998, 39(8), 1327-1334.
31. Ding, Y.S.; Fowler, J.S.; Gatley, S.J.; Dewey, S.L.; Wolf, A.P.; Schlyer, D.J. Synthesis of high specific activity 6-[18F] fluorodopamine for positron emission tomography studies of sympathetic nervous tissue. J Med Chem. 1991; 34: 861-863.
32. Wieland, D.M.; Rosenspire, K.C.; Hutchins, G.D.; Van Dort, M.; Rothley, J.M.; Mislankar, S.G.; Lee, H.T.; Massin, C.C.; Gildersleeve, D.L.; Sherman, P.S. Neuronal mapping of the heart with 6-[18]fluorometaraminol. J. Med. Chem., 1990, 33(3), 956-964.
33. Thackeray, J.T.; Bengel, F.M. Assessment of cardiac autonomic neuronal function using PET imaging. J. Nucl. Cardiol., 2013, 20(1): 150-65.